Infectious Diseases

April 10, 2025

$4.1 million grant awarded to study unnecessary antibiotic prescriptions 

Antibiotic prescriptions handed out in unplanned care spaces contribute to antimicrobial resistance, especially if they are not necessary to treat infections.

By Evan Dorian
April 8, 2025

A link between bacterial infection and colorectal cancer: study

Understanding factors that contribute to the development of colorectal cancer could point to new targets for treating the disease at earlier stages, when survival rates are highest.

By Leigh MacMillan
March 25, 2025

C. diff uses toxic compound to fuel growth advantage

The findings of a new research study increase understanding of the molecular drivers of C. diff infection and point to novel therapeutic strategies aimed at a pathogen that causes about half a million infections in the U.S. each year.

By Leigh MacMillan
March 10, 2025

VUMC to develop AI technology for therapeutic antibody discovery

The approach will address “bottlenecks” that slow the traditional antibody discovery process, and it aims to make it possible to generate monoclonal antibody therapies against any target of interest.

By Leigh MacMillan
(iStock)
January 23, 2025

$20 million grant supports sweeping study of human viruses

Most of the more than 200 species of viruses known to reside in humans remain poorly understood, and new ones are being discovered every few months.

By Paul Govern
January 23, 2025

Eric Skaar wins National Academy of Sciences award

Skaar, who directs the Vanderbilt Institute for Infection, Immunology and Inflammation, is being recognized for “pioneering work at the intersection of nutrition and infectious diseases.”

By Leigh MacMillan
December 17, 2024

Immune-suppressing drug does not improve COVID-19 recovery: study

Previous studies suggested that fostamatinib may suppress inflammatory responses triggered by COVID-19 and mitigate ongoing lung injury, decreasing mortality and oxygen requirements.
By Bill Snyder
December 13, 2024

Respiratory virus activity increasing in Middle Tennessee; important reminders from Infection Prevention

To reduce your risk of becoming ill and to create a safe environment for our coworkers and patients, a reminder of these essential infection prevention precautions
By VUMC Infection Prevention team
December 12, 2024

Go inside the lab as Maddie Wright, a CF warrior, ‘geeks out’ over the science of Vanderbilt Medical Laboratories 

A 17-year-old cystic fibrosis warrior and liver transplant recipient with antibiotic resistance got to see science in action at Vanderbilt Medical Laboratories.
By Jessica Pasley and Erin O. Smith
December 11, 2024

Vanderbilt joins national effort to develop alphavirus vaccines

The project aims to design computational “tool kits” that can speed development of multi-virus vaccines targeting some of the greatest infectious threats to human health.
By Bill Snyder and Herschel Pollard
November 15, 2024

Zinc deficiency promotes Acinetobacter lung infection: study

The study findings point to the potential of interleukin-13 antibodies — approved for use in humans — as a treatment to protect against bacterial pneumonia in patients with zinc deficiency.
By Leigh MacMillan
November 6, 2024

Number of whooping cough cases on rise nationally

While it has been difficult to pinpoint the reason for the rise in cases, waning immunity and vaccine hesitancy may be the likely culprits.
By Jessica Pasley
October 25, 2024

Asthma drug does not speed COVID-19 recovery: study

The study, a randomized and controlled clinical trial, tested the effectiveness of montelukast in 1,250 outpatients with acute post-COVID-19 symptoms.
By Bill Snyder and Shantell Kirkendoll
1 2 3 … 11